Voronezh State Medical University named after N. N. Burdenko is located in Voronezh, Russia.

During the past decade, State Health Institution "Voronezh Region Clinical Oncology Dispansary" conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "State Health Institution "Voronezh Region Clinical Oncology Dispansary"" are "Non-small Cell Lung Cancer" (1 trials) and "Patients With Solid Tumours Who Receive Myelosupressive Therapy" (1 trials). Many other conditions were trialed in "State Health Institution "Voronezh Region Clinical Oncology Dispansary"" in a lesser frequency.

Most popular intervention types in "State Health Institution "Voronezh Region Clinical Oncology Dispansary"" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "Carboplatin" (1 trials), "Empegfilgrastim" (1 trials) and "Paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "State Health Institution "Voronezh Region Clinical Oncology Dispansary"" are 2 trials for "All" genders.

Currently, there are NaN active trials in "State Health Institution "Voronezh Region Clinical Oncology Dispansary"". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in State Health Institution "Voronezh Region Clinical Oncology Dispansary", undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in State Health Institution "Voronezh Region Clinical Oncology Dispansary", 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".